查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
生命科學工具市場規模、份額和趨勢分析報告，按技術、產品、最終用途、地區、細分市場預測 2023-2030 年
市場調查報告書
商品編碼
1233226

生命科學工具市場規模、份額和趨勢分析報告，按技術、產品、最終用途、地區、細分市場預測 2023-2030 年

Life Science Tools Market Size, Share & Trends Analysis Report By Technology (Cell Biology, Proteomics), By Product, By End-use (Government & Academic, Healthcare), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 265 Pages | 商品交期: 2-10個工作天內

價格

生命科學工具市場增長和趨勢

根據 Grand View Research, Inc. 的最新報告，全球生命科學工具市場規模預計從 2023 年到 2030 年將以 10.8% 的複合年增長率增長，到 2030 年將達到 3306.9 億美元。

這種增長歸因於政府對生命科學技術的資助增加、對細胞和基因療法的需求、生物製藥的採用增加以及來自市場主要參與者的競爭加劇。

全球 COVID-19 病例激增需要快速診斷以遏制疾病的傳播，這在大流行期間增加了對生命科學工具的需求，對市場產生了積極影響。傳染病的快速診斷、有效的治療和預防計劃對於 COVID-19 大流行期間的病例管理至關重要。目前，為確認 SARS-CoV-2 感染而開發具有成本效益的接觸點檢測試劑盒和高效調查方法的競賽正在推動診斷創新的新領域。在這次大流行期間，美國食品和藥物管理局已向多項診斷測試授予緊急使用授權 (EUA)，使它們能夠快速且易於使用。例如，2022 年 5 月，美國 FDA 向 Abbott Diagnostics Scarborough, Inc. 的快速體外診斷測試 ID NOW COVID-19 2.0 授予 EUA。此外，還有廣泛的非處方 COVID-19 測試，這將進一步促進收入。

此外，生命科學工具行業正在擴大基於政府對研究和技術進步的投資增加。美國國家人類基因組研究所 (NHGRI) 和美國國立衛生研究院 (NIH) 等組織積極資助各種生命科學項目。例如，NIH 已資助 4D 核組計劃 2500 萬美元，以瞭解核組織的基因調控和細胞表達。此外，美國政府還資助多家生命科學公司用於研發目的。例如，Biomedical Advanced Research and Development Authority（BARDA）計劃頒發價值 750,000 美元的獎項，以促進醫療保健領域創新技術的發展。因此，增加政府對技術和生命科學研究的資助預計將在未來幾年推動市場。

領先企業還通過提供先進的工具和技術為市場的增長做出貢獻。此外，每家公司都在向市場推出新的自動化解決方案，這為市場增長提供了有利可圖的機會。例如，2022 年 2 月，Covaris, LLC. 宣佈推出 truXTRAC FFPE Total NA Auto 96 Kit，這是一個全自動工作流程，包括所有必要的配件、耗材和試劑。該自動化套件由自適應聚焦聲學 (AFA) 技術提供支持，可在 5 小時內對 FFPE（福爾馬林固定石蠟包埋）樣品進行 RNA 和 DNA 純化和提取。創新解決方案的推出有望在不久的將來推動市場。

生命科學工具市場報告亮點

  • 從技術來看，2022年細胞生物學技術將佔據最大份額。為使用和採用乾細胞、CAR T 細胞、TCR T 細胞、NK T 細胞和其他細胞療法而引入的新技術預計將推動該領域的創收。
  • 分產品來看，2022年細胞培養系統和3D細胞培養領域佔比最大。細胞生物學在生命科學行業越來越受歡迎，並為該領域產生的收入做出了重大貢獻。
  • 按最終用途劃分，醫療保健領域將在 2022 年產生最高收入。診所、醫院和診斷實驗室越來越多地採用蛋白質組學和基因組學工作流程來治療和診斷多種臨床表現異常，預計這將推動市場發展。
  • 2022年，北美收入佔比最大。在該地區，基因組學、蛋白質組學、腫瘤學和診斷篩查的快速採用有助於區域增長。此外，許多領先的市場參與者繼續為該地區的生命科學研究開發先進的工具。
  • 預計亞太地區在預測期內的增長率最高。為了利用未開發的道路和有利可圖的機會，全球公司在該地區的投資正在推動該地區的市場。

目錄

第一章 調查方法和範圍

  • 調查方法
  • 調查假設
  • 信息採購
    • 購買的數據庫
    • GVR內部數據庫
    • 次要信息
    • 次要信息
    • 初步調查
    • 生命科學工具市場研究的樣本量：
      • 主要信息：
      • 初步調查詳情
      • 次要數據源：
  • 信息或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 市場模式
    • 核酸製劑市場
    • 細胞生物學市場
      • 3D 細胞培養技術的比較
    • 下一代測序和轉染電穿孔市場
    • 技術市場研究
      • 用於技術市場份額評估的 Qfd 建模
    • 最終用途的市場調查
  • 全球市場：複合年增長率計算
  • 目的

第二章執行摘要

  • 市場快照
  • 段快照
  • 競爭格局的快照

3. 市場變量、趨勢和範圍

  • 市場細分和範圍
  • 市場趨勢和前景
  • 市場系列展望
    • 相關/子公司市場展望
  • 市場動態
    • 市場驅動力分析
      • 增加政府對生命科學技術的資助
      • 細胞生長和基因治療
      • 對生物製藥（生物製劑和生物仿製藥）的需求不斷增長
      • 生命科學工具的技術進步
      • 基因組學和蛋白質組學技術在精準醫學中的應用
    • 市場約束因素分析
      • 某些技術成本高
      • 缺乏熟練的專業人員
    • 市場機會分析
      • 在病毒分析中的用途
      • 戰略交易和發展的數量增加
  • 2022 年技術採用和增長前景圖（百萬美元）
  • COVID-19 大流行對全球生命科學工具市場的影響
    • 對供應鏈的影響
    • 對生命科學和醫療保健行業的影響
  • 營商環境分析
    • SWOT 分析；按因素（政治和法律、經濟、技術）
    • 波特五力分析

第四章技術業務分析

  • 生命科學工具市場：技術波動分析
  • 基因組技術
  • 蛋白質組學技術
  • 細胞生物學技術
  • 其他分析和樣品製備技術
  • 實驗室用品和技術

第五章產品經營分析

  • 生命科學工具市場：產品差異分析
  • 細胞培養系統和 3D 細胞培養
    • 機器
    • 消耗品
    • 細胞和組織培養服務
  • 液相色譜法 (Lc)
    • 機器
    • 消耗品
    • 服務
  • 質譜 (Ms)
    • 機器
    • 消耗品
    • 服務
  • 新一代測序 (Ngs)
    • 機器
    • 消耗品
    • 服務
  • 聚合酶鏈反應與定量聚合酶鏈反應
    • 機器
    • 消耗品
    • 服務
  • 流式細胞儀
    • 機器
    • 消耗品
    • 服務
  • 核磁共振波譜 (Nmr)
    • 機器
    • 消耗品
    • 服務
  • 顯微鏡和電子顯微鏡
    • 機器
    • 消耗品
    • 服務
  • 核酸製備（小睡）
    • 機器
    • 消耗品
    • 服務
  • 轉染裝置和基因傳遞技術
    • 設備
    • 試劑
  • 克隆和基因組工程
    • 試劑盒、試劑和耗材
    • 服務
  • 核酸微陣列
    • 機器
    • 消耗品
    • 服務
  • 桑格測序
    • 機器
    • 消耗品
    • 服務
  • 其他分離技術
    • 機器
    • 消耗品
    • 服務
  • 其他產品和服務
    • 抗體
    • 一般物品
    • 其他
      • 機器
      • 消耗品
      • 服務

第 6 章最終用途業務分析

  • 生命科學工具市場：最終用途變化分析
  • 政府和學術界
  • 生物製藥公司
  • 衛生保健
  • 工業應用
  • 其他

7. 生命科學工具市場：按產品、技術和最終用途分類的區域估計和趨勢分析

  • 北美
    • SWOT分析：
    • 美國
      • 主要國家動態
      • 競爭情景
      • 市場情景
      • 監管框架
      • 贖回場景
    • 加拿大
      • 主要國家動態
      • 競爭情景
      • 市場情景
      • 監管框架
      • 贖回場景
  • 歐洲
    • SWOT分析：
    • 德國
      • 主要國家動態
      • 競爭情景
      • 市場情景
      • 監管框架
      • 贖回場景
    • 英國
      • 主要國家動態
      • 競爭情景
      • 市場情景
      • 贖回場景
    • 法國
      • 主要國家動態
      • 競爭情景
      • 市場情景
    • 意大利
      • 主要國家動態
      • 競爭情景
      • 市場情景
      • 監管框架
    • 西班牙
      • 主要國家動態
      • 競爭情景
      • 市場情景
      • 2020年西班牙批准的生物技術研發項目
    • 瑞士
      • 競爭情景
      • 併購與合作，2020-2022
    • 丹麥
      • 主要國家動態
      • 投資丹麥東部當前和未來的生物技術公司
      • 監管框架
    • 挪威
      • 主要國家動態
      • 基於 2021 年收入的頂級生物技術公司
      • 監管框架
    • 瑞典
      • 主要國家動態
      • 市場概況
      • 癌症患病率
      • 監管框架
  • 亞太地區
    • SWOT分析：
    • 日本
      • 主要國家動態
      • 競爭情景
      • 市場情景
      • 監管框架
      • 贖回場景
    • 中國
      • 主要國家動態
      • 競爭情景
      • 市場情景
      • 監管框架
      • 贖回場景
    • 印度
      • 主要國家動態
      • 競爭情景
      • 市場情景
      • 監管框架
    • 韓國
      • 主要國家動態
      • 競爭情景
      • 市場情景
      • 技術集群個性化醫療公共研發項目趨勢
      • 監管框架
      • 贖回場景
    • 澳大利亞
      • 主要國家動態
      • 競爭情景
      • 市場情景
      • 贖回場景
    • 新加坡
      • 主要國家動態
      • 競爭情景
      • 贖回場景
    • 泰國
      • 主要國家動態
      • 泰國主要疾病流行情況
      • 監管框架
      • 贖回場景
  • 拉丁美洲
    • SWOT分析：
    • 阿根廷
      • 主要國家動態
      • 市場情景
      • 監管場景
      • 贖回場景
    • 巴西
      • 主要國家動態
      • 競爭情景
      • 市場情景
      • 監管框架
    • 墨西哥
      • 主要國家動態
      • 競爭情景
      • 市場情景
  • 中東和非洲
    • SWOT分析：
    • 南非
      • 主要國家動態
      • 競爭情景
      • 市場情景
      • 贖回場景
      • 監管框架
    • 阿拉伯聯合酋長國
      • 主要國家動態
      • 競爭情景
      • 市場情景
      • 監管框架
    • 沙特阿拉伯
      • 主要國家動態
      • 競爭情景
      • 市場情景
      • 監管框架
      • 贖回場景
    • 科威特
      • 主要國家動態
      • 競爭情景
      • 科威特醫療保健行業的主要發展
      • 監管框架

第八章競爭格局

  • 公司分類
  • 公司市場定位
  • 2022 年公司市場份額分析
  • 企業熱圖分析
  • 戰略規劃
  • 公司簡介/名單
    • Thermo Fisher Scientific Inc.
      • Overview
      • Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 產品對標
      • 戰略舉措
    • Danaher Corporation
      • Overview
      • Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 產品對標
      • 戰略舉措
    • Illumina, Inc.
      • Overview
      • Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 產品對標
      • 戰略舉措
    • Merck Kgaa
      • Overview
      • Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 產品對標
      • 戰略舉措
    • BD
      • Overview
      • Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 產品對標
      • 戰略舉措
    • Qiagen
      • Overview
      • Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 產品對標
      • 戰略舉措
    • Bio-Rad Laboratories Inc.
      • Overview
      • Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 產品對標
      • 戰略舉措
    • Agilent Technologies, Inc.
      • Overview
      • Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 產品對標
      • 戰略舉措
    • Hitachi, Ltd.
      • Overview
      • Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 產品對標
      • 戰略舉措
    • F. Hoffmann-La Roche Ltd
      • Overview
      • Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 產品對標
      • 戰略舉措
    • Bruker
      • Overview
      • Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 產品對標
      • 戰略舉措
    • Oxford Instruments Plc
      • Overview
      • Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 產品對標
      • 戰略舉措
    • Zeiss International
      • Overview
      • Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 產品對標
      • 戰略舉措
    • Shimadzu Corporation
      • Overview
      • Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 產品對標
      • 戰略舉措
Product Code: GVR-4-68038-505-2

Life Science Tools Market Growth & Trends:

The global life science tools market size is expected to reach USD 330.69 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 10.8% from 2023 to 2030. This growth can be attributed to a rise in government funding for life science technologies, demand for cell and gene therapies, an increase in the adoption of biopharmaceuticals, and growing competition among prominent companies in the market.

The exponential rise of COVID-19 cases globally requires rapid diagnosis for containment of the spread of infectious disease, which boosted the demand for life science tools during the pandemic and had a positive impact on the market. Rapid diagnosis of the infection, effective treatments, and preventative plans are essential for the management of cases during the COVID-19 pandemic. The current race for the development of cost-effective point-of-contact test kits and efficient laboratory methodologies for confirmation of SARS-CoV-2 infection has driven a new frontier of diagnostic innovation. During this pandemic, the U.S. FDA granted Emergency Use Authorizations (EUAs) to several diagnostic tests to make them rapidly and easily available for use. For example, in May 2022, the U.S. FDA granted a EUA to ID NOW COVID-19 2.0, a rapid in-vitro diagnostic test by Abbott Diagnostics Scarborough, Inc. Moreover, a wide range of commercial COVID-19 tests is available in the marketplace, which will further add to revenue generation.

Additionally, the life science tools industry is expanding based on the increasing investments by the government for the advancement of research and technologies. Organizations such as The National Human Genome Research Institute (NHGRI) and the National Institutes of Health (NIH) are actively funding various life science projects. For instance, the NIH funded USD 25 million for the '4D Nucleome Program', which aims to understand gene regulation and cellular expression via the nuclear organization. Moreover, the U.S. government has funded several life sciences companies for R&D purposes. For instance, the Biomedical Advanced Research and Development Authority (BARDA) has planned to make awards worth USD 750,000 to facilitate the development of innovative technologies in the healthcare sector. Thus, the increase in government funding for life science research as well as technologies is expected to drive the market in the coming years.

Key players are also contributing to the growth of the market by providing advanced tools and techniques. Furthermore, companies are introducing new automated solutions in the market, which, in turn, provide lucrative opportunities for market growth. For instance, in February 2022, Covaris, LLC. announced the launch of truXTRAC FFPE Total NA Auto 96 Kit, a fully automated workflow comprising all necessary accessories, consumables, and reagents. This automated kit is powered by Adaptive Focused Acoustics (AFA) technology that allows both purification and extraction of RNA & DNA for FFPE (formalin fixed paraffin embedded) samples in 5 hours. The introduction of innovative solutions is expected to drive the market in the near future.

Life Science Tools Market Report Highlights:

  • By technology, cell biology technology accounted for the largest share in 2022. The introduction of novel technologies for the usage and adoption of stem cells, CAR T-cells, TCR T-cells, NK T-cells, and other cell therapies is expected to boost revenue generation in this segment
  • By product, the cell culture systems and 3D cell culture segment held the largest share in 2022. Cell biology is gaining popularity across multiple aspects in the life science industry, which is contributing significantly to the revenue generated by this segment
  • By end-use, the healthcare segment generated the highest revenue in 2022. The rise in adoption of proteomic and genomic workflows in clinics, hospitals, and diagnostic laboratories for the treatment and diagnosis of several clinically presented abnormalities is anticipated to drive the market
  • North America accounted for the largest revenue share in 2022. The rapid adoption of genomics, proteomics, oncology, and diagnostic screening in the region has contributed to regional growth. In addition, a number of major market players are continuously engaged in the development of advanced tools for life science research in this region
  • Asia Pacific is expected to grow at the highest rate over the projected period. Investments by global companies in this region to utilize the untapped avenue and lucrative opportunities will drive the regional market

Table of Contents

Chapter 1 Methodology And Scope

  • 1.1 Research Methodology
  • 1.2 Research Assumptions
    • 1.2.1 Estimates And Forecast Timeline
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Secondary Sources
    • 1.3.5 Primary Research
    • 1.3.6 Sample Size For The Study On Life Science Tools Market:
      • 1.3.6.1 Primary Sources:
      • 1.3.6.2 Details Of Primary Research
      • 1.3.6.3 Secondary Data Sources:
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Market Model
    • 1.6.1 Nucleic Acid Preparation Market
    • 1.6.2 Cell Biology Market
      • 1.6.2.1 Comparison Of 3d Cell Culture Techniques
    • 1.6.3 Next-Generation Sequencing & Transfection Electroporation Market
    • 1.6.4 Market Study, By Technology
      • 1.6.4.1 Qfd Modeling For Market Share Assessment Of Technologies
    • 1.6.5 Market Study, By End Use
  • 1.7 Global Market: Cagr Calculation
  • 1.8 Objectives
    • 1.8.1 Objective 1:
    • 1.8.2 Objective 2:

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Snapshot
  • 2.3 Competitive Landscape Snapshot

Chapter 3 Market Variables, Trends, And Scope

  • 3.1 Market Segmentation & Scope
  • 3.2 Market Trends & Outlook
  • 3.3 Market Lineage Outlook
    • 3.3.1 Related/Ancillary Market Outlook
  • 3.4 Market Dynamics
    • 3.4.1 Market Driver Analysis
      • 3.4.1.1 Increased Government Funding For Life Science Technologies
      • 3.4.1.2 Growth Of Cell And Gene Therapies
      • 3.4.1.3 Rise In The Demand For Biopharmaceuticals (Biologics & Biosimilars)
      • 3.4.1.4 Technological Advancements In Life Science Tools
      • 3.4.1.5 Applications Of Genomic And Proteomic Technologies For Precision Medicine
    • 3.4.2 Market Restraint Analysis
      • 3.4.2.1 High Cost For Some Technologies
      • 3.4.2.2 Dearth Of Skilled Professionals
    • 3.4.3 Market Opportunity Analysis
      • 3.4.3.1 Utility In Viral Analysis
      • 3.4.3.2 Rise In The Number Of Strategic Deals & Developments
  • 3.5 Penetration And Growth Prospect Mapping For Technology, 2022 (USD Million)
  • 3.6 Impact Of Covid-19 Pandemic On Global Life Science Tools Market
    • 3.6.1 Impact On The Supply Chain
    • 3.6.2 Impact On Life Sciences & Healthcare Industry
  • 3.7 Business Environment Analysis
    • 3.7.1 Swot Analysis; By Factor (Political & Legal, Economic, And Technological)
    • 3.7.2 Porter's Five Forces Analysis

Chapter 4 Technology Business Analysis

  • 4.1 Life Science Tools Market: Technology Movement Analysis
  • 4.2 Genomic Technology
    • 4.2.1 Genomic Technology Market Estimates And Forecast, 2018 - 2030 (USD Billion)
  • 4.3 Proteomics Technology
    • 4.3.1 Proteomics Technology Market Estimates And Forecast, 2018 - 2030 (USD Billion)
  • 4.4 Cell Biology Technology
    • 4.4.1 Cell Biology Technology Market Estimates And Forecast, 2018 - 2030 (USD Billion)
  • 4.5 Other Analytical & Sample Preparation Technology
    • 4.5.1 Other Analytical & Sample Preparation Technology Market Estimates And Forecast, 2018 - 2030 (USD Billion)
  • 4.6 Lab Supplies & Technologies
    • 4.6.1 Lab Supplies & Technology Market Estimates And Forecast, 2018 - 2030 (USD Billion)

Chapter 5 Product Business Analysis

  • 5.1 Life Science Tools Market: Product Movement Analysis
  • 5.2 Cell Culture Systems & 3d Cell Culture
    • 5.2.1 Life Science Tools Market For Cell Culture Systems & 3d Cell Culture, 2018 - 2030 (USD Million)
    • 5.2.2 Instruments
    • 5.2.3 Consumables
    • 5.2.4 Cell & Tissue Culture Services
  • 5.3 Liquid Chromatography (Lc)
    • 5.3.1 Life Science Tools Market For Liquid Chromatography, 2018 - 2030 (USD Million)
    • 5.3.2 Instruments
    • 5.3.3 Consumables
    • 5.3.4 Services
  • 5.4 Mass Spectrometry (Ms)
    • 5.4.1 Life Science Tools Market For Mass Spectrometry, 2018 - 2030 (USD Million)
    • 5.4.2 Instruments
    • 5.4.3 Consumables
    • 5.4.4 Services
  • 5.5 Next-Generation Sequencing (Ngs)
    • 5.5.1 Life Science Tools Market Estimates And Forecast For Ngs, 2018 - 2030 (USD Billion)
    • 5.5.2 Instruments
    • 5.5.3 Consumables
    • 5.5.4 Services
  • 5.6 Pcr & Qpcr
    • 5.6.1 Life Science Tools Market Estimates And Forecast For Pcr & Qpcr, 2018 - 2030 (USD Million)
    • 5.6.2 Instruments
    • 5.6.3 Consumables
    • 5.6.4 Services
  • 5.7 Flow Cytometry
    • 5.7.1 Life Science Tools Market For Flow Cytometry, 2018 - 2030 (USD Million)
    • 5.7.2 Instruments
    • 5.7.3 Consumables
    • 5.7.4 Services
  • 5.8 Nuclear Magnetic Resonance Spectroscopy (Nmr)
    • 5.8.1 Life Science Tools Market For Nuclear Magnetic Resonance Spectroscopy, 2018 - 2030 (USD Million)
    • 5.8.2 Instruments
    • 5.8.3 Consumables
    • 5.8.4 Services
  • 5.9 Microscopy & Electron Microscopy
    • 5.9.1 Life Science Tools Market For Microscopy & Electron Microscopy, 2018 - 2030 (USD Million)
    • 5.9.2 Instruments
    • 5.9.3 Consumables
    • 5.9.4 Services
  • 5.10 Nucleic Acid Preparation (Nap)
    • 5.10.1 Life Science Tools Market For Nucleic Acid Preparation, 2018 - 2030 (USD Million)
    • 5.10.2 Instruments
    • 5.10.3 Consumables
    • 5.10.4 Services
  • 5.11 Transfection Devices & Gene Delivery Technologies
    • 5.11.1 Life Science Tools Market For Transfection Devices & Gene Delivery Technologies, 2018 - 2030 (USD Million)
    • 5.11.2 Equipment
    • 5.11.3 Reagents
  • 5.12 Cloning & Genome Engineering
    • 5.12.1 Life Science Tools Market For Cloning & Genome Engineering, 2018 - 2030 (USD Million)
    • 5.12.2 Kits, Reagents, And Consumables
    • 5.12.3 Services
  • 5.13 Nucleic Acid Microarray
    • 5.13.1 Life Science Tools Market For Nucleic Acid Microarray, 2018 - 2030 (USD Million)
    • 5.13.2 Instruments
    • 5.13.3 Consumables
    • 5.13.4 Services
  • 5.14 Sanger Sequencing
    • 5.14.1 Life Science Tools Market For Sanger Sequencing, 2018 - 2030 (USD Million)
    • 5.14.2 Instrument
    • 5.14.3 Consumables
    • 5.14.4 Services
  • 5.15 Other Separation Technologies
    • 5.15.1 Life Science Tools Market For Other Separation Technologies, 2018 - 2030 (USD Million)
    • 5.15.2 Instrument
    • 5.15.3 Consumables
    • 5.15.4 Services
  • 5.16 Other Products & Services
    • 5.16.1 Life Science Tools Market For Other Products & Services, 2018 - 2030 (USD Million)
    • 5.16.2 Antibodies
    • 5.16.3 General Supplies
    • 5.16.4 Others
      • 5.16.4.1 Life Science Tools Market For Others, 2018 - 2030 (USD Million)
      • 5.16.4.2 Instruments
      • 5.16.4.3 Consumables
      • 5.16.4.4 Services

Chapter 6 End-Use Business Analysis

  • 6.1 Life Science Tools Market: End-Use Movement Analysis
  • 6.2 Government & Academic
    • 6.2.1 Life Science Tools Market For Government & Academic End Use, 2018 - 2030 (USD Billion)
  • 6.3 Biopharmaceutical Company
    • 6.3.1 Life Science Tools Market For Biopharmaceutical Companies, 2018 - 2030 (USD Billion)
  • 6.4 Healthcare
    • 6.4.1 Life Science Tools Market For Health Care End Use, 2018 - 2030 (USD Billion)
  • 6.5 Industrial Applications
    • 6.5.1 Life Science Tools Market For Industry End Use, 2018 - 2030 (USD Billion)
  • 6.6 Other
    • 6.6.1 Life Science Tools Market For Other End Use, 2018 - 2030 (USD Billion)

Chapter 7 Life Sciences Tools Market: Regional Estimates And Trend Analysis, By Product, Technology, & End-Use

  • 7.1 North America
    • 7.1.1 Swot Analysis:
      • 7.1.1.1 North America Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.1.2 U.S.
      • 7.1.2.1 Key Country Dynamics
      • 7.1.2.2 Competitive Scenario
      • 7.1.2.3 Market Scenario
      • 7.1.2.4 Regulatory Framework
      • 7.1.2.5 Reimbursement Scenario
      • 7.1.2.6 U.S. Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.1.3 Canada
      • 7.1.3.1 Key Country Dynamics
      • 7.1.3.2 Competitive Scenario
      • 7.1.3.3 Market Scenario
      • 7.1.3.4 Regulatory Framework
      • 7.1.3.5 Reimbursement Scenario
      • 7.1.3.6 Canada Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 7.2 Europe
    • 7.2.1 Swot Analysis:
      • 7.2.1.1 Europe Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.2.2 Germany
      • 7.2.2.1 Key Country Dynamics
      • 7.2.2.2 Competitive Scenario
      • 7.2.2.3 Market Scenario
      • 7.2.2.4 Regulatory Framework
      • 7.2.2.5 Reimbursement Scenario
      • 7.2.2.6 Germany Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.2.3 UK
      • 7.2.3.1 Key Country Dynamics
      • 7.2.3.2 Competitive Scenario
      • 7.2.3.3 Market Scenario
      • 7.2.3.4 Reimbursement Scenario
      • 7.2.3.5 UK Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.2.4 France
      • 7.2.4.1 Key Country Dynamics
      • 7.2.4.2 Competitive Scenario
      • 7.2.4.3 Market Scenario
      • 7.2.4.4 France Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.2.5 Italy
      • 7.2.5.1 Key Country Dynamics
      • 7.2.5.2 Competitive Scenario
      • 7.2.5.3 Market Scenario
      • 7.2.5.4 Regulatory Framework
      • 7.2.5.5 Italy Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.2.6 Spain
      • 7.2.6.1 Key Country Dynamics
      • 7.2.6.2 Competitive Scenario
      • 7.2.6.3 Market Scenario
      • 7.2.6.4 Biotechnology R&D Projects Approved In Spain In 2020
      • 7.2.6.5 Spain Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.2.7 Switzerland
      • 7.2.7.1 Competitive Scenario
      • 7.2.7.2 M&A And Collaborations, 2020-2022
      • 7.2.7.3 Switzerland Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.2.8 Denmark
      • 7.2.8.1 Key Country Dynamics
      • 7.2.8.2 Current And Upcoming Biotech Companies Investments In Eastern Denmark
      • 7.2.8.3 Regulatory Framework
      • 7.2.8.4 Denmark Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.2.9 Norway
      • 7.2.9.1 Key Country Dynamics
      • 7.2.9.2 Top Biotechnology Companies, Based On Revenue As Of 2021
      • 7.2.9.3 Regulatory Framework
      • 7.2.9.4 Norway Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.2.10 Sweden
      • 7.2.10.1 Key Country Dynamics
      • 7.2.10.2 Market Overview
      • 7.2.10.3 Cancer Prevalance
      • 7.2.10.4 Regulatory Framework
      • 7.2.10.5 Sweden Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 7.3 Asia Pacific
    • 7.3.1 Swot Analysis:
      • 7.3.1.1 Asia Pacific Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.3.2 Japan
      • 7.3.2.1 Key Country Dynamics
      • 7.3.2.2 Competitive Scenario
      • 7.3.2.3 Market Scenario
      • 7.3.2.4 Regulatory Framework
      • 7.3.2.5 Reimbursement Scenario
      • 7.3.2.6 Japan Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.3.3 China
      • 7.3.3.1 Key Country Dynamics
      • 7.3.3.2 Competitive Scenario
      • 7.3.3.3 Market Scenario
      • 7.3.3.4 Regulatory Framework
      • 7.3.3.5 Reimbursement Scenario
      • 7.3.3.6 China Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.3.4 India
      • 7.3.4.1 Key Country Dynamics
      • 7.3.4.2 Competitive Scenario
      • 7.3.4.3 Market Scenario
      • 7.3.4.4 Regulatory Framework
      • 7.3.4.5 India Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.3.5 South Korea
      • 7.3.5.1 Key Country Dynamics
      • 7.3.5.2 Competitive Scenario
      • 7.3.5.3 Market Scenario
      • 7.3.5.4 Trend Of Public R&D Projects For Personalized Medicine By Technology Clusters
      • 7.3.5.5 Regulatory Framework
      • 7.3.5.6 Reimbursement Scenario
      • 7.3.5.7 South Korea Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.3.6 Australia
      • 7.3.6.1 Key Country Dynamics
      • 7.3.6.2 Competitive Scenario
      • 7.3.6.3 Market Scenario
      • 7.3.6.4 Reimbursement Scenario
      • 7.3.6.5 Australia Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.3.7 Singapore
      • 7.3.7.1 Key Country Dynamics
      • 7.3.7.2 Competitive Scenario
      • 7.3.7.3 Reimbursement Scenario
      • 7.3.7.4 Singapore Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.3.8 Thailand
      • 7.3.8.1 Key Country Dynamics
      • 7.3.8.2 Thailand Key Disease Prevalence
      • 7.3.8.3 Regulatory Framework
      • 7.3.8.4 Reimbursement Scenario
      • 7.3.8.5 Thailand Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 7.4 Latin America
    • 7.4.1 Swot Analysis:
      • 7.4.1.1 Latin America Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.2 Argentina
      • 7.4.2.1 Key Country Dynamics
      • 7.4.2.2 Market Scenario
      • 7.4.2.3 Regulatory Scenario
      • 7.4.2.4 Reimbursement Scenario
      • 7.4.2.5 Argentina Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.3 Brazil
      • 7.4.3.1 Key Country Dynamics
      • 7.4.3.2 Competitive Scenario
      • 7.4.3.3 Market Scenario
      • 7.4.3.4 Regulatory Framework
      • 7.4.3.5 Brazil Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.4 Mexico
      • 7.4.4.1 Key Country Dynamics
      • 7.4.4.2 Competitive Scenario
      • 7.4.4.3 Market Scenario
      • 7.4.4.4 Mexico Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 7.5 Middle East And Africa
    • 7.5.1 Swot Analysis:
      • 7.5.1.1 MEA Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.2 South Africa
      • 7.5.2.1 Key Country Dynamics
      • 7.5.2.2 Competitive Scenario
      • 7.5.2.3 Market Scenario
      • 7.5.2.4 Reimbursement Scenario
      • 7.5.2.5 Regulatory Framework
      • 7.5.2.6 South Africa Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.3 UAE
      • 7.5.3.1 Key Country Dynamics
      • 7.5.3.2 Competitive Scenario
      • 7.5.3.3 Market Scenario
      • 7.5.3.4 Regulatory Framework
      • 7.5.3.5 Uae Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.4 Saudi Arabia
      • 7.5.4.1 Key Country Dynamics
      • 7.5.4.2 Competitive Scenario
      • 7.5.4.3 Market Scenario
      • 7.5.4.4 Regulatory Framework
      • 7.5.4.5 Reimbursement Scenario
      • 7.5.4.6 Saudi Arabia Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.5 Kuwait
      • 7.5.5.1 Key Country Dynamics
      • 7.5.5.2 Competitive Scenario
      • 7.5.5.3 Key Development In Healthcare Sector Of Kuwait
      • 7.5.5.4 Regulatory Framework
      • 7.5.5.5 Kuwait Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 8 Competitive Landscape

  • 8.1 Company Categorization
  • 8.2 Company Market Positioning
  • 8.3 Company Market Share Analysis, 2022
  • 8.4 Company Heat Map Analysis
  • 8.5 Strategy Mapping
  • 8.6 Company Profiles/Listing
    • 8.6.1 Thermo Fisher Scientific Inc.
      • 8.6.1.1. Overview
      • 8.6.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.6.1.3. Product Benchmarking
      • 8.6.1.4. Strategic Initiatives
    • 8.6.2 Danaher Corporation
      • 8.6.2.1. Overview
      • 8.6.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.6.2.3. Product Benchmarking
      • 8.6.2.4. Strategic Initiatives
    • 8.6.3 Illumina, Inc.
      • 8.6.3.1. Overview
      • 8.6.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.6.3.3. Product Benchmarking
      • 8.6.3.4. Strategic Initiatives
    • 8.6.4 Merck Kgaa
      • 8.6.4.1. Overview
      • 8.6.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.6.4.3. Product Benchmarking
      • 8.6.4.4. Strategic Initiatives
    • 8.6.5 BD
      • 8.6.5.1. Overview
      • 8.6.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.6.5.3. Product Benchmarking
      • 8.6.5.4. Strategic Initiatives
    • 8.6.6 Qiagen
      • 8.6.6.1. Overview
      • 8.6.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.6.6.3. Product Benchmarking
      • 8.6.6.4. Strategic Initiatives
    • 8.6.7 Bio-Rad Laboratories Inc.
      • 8.6.7.1. Overview
      • 8.6.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.6.7.3. Product Benchmarking
      • 8.6.7.4. Strategic Initiatives
    • 8.6.8 Agilent Technologies, Inc.
      • 8.6.8.1. Overview
      • 8.6.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.6.8.3. Product Benchmarking
      • 8.6.8.4. Strategic Initiatives
    • 8.6.9 Hitachi, Ltd.
      • 8.6.9.1. Overview
      • 8.6.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.6.9.3. Product Benchmarking
      • 8.6.9.4. Strategic Initiatives
    • 8.6.10 F. Hoffmann-La Roche Ltd
      • 8.6.10.1. Overview
      • 8.6.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.6.10.3. Product Benchmarking
      • 8.6.10.4. Strategic Initiatives
    • 8.6.11 Bruker
      • 8.6.11.1. Overview
      • 8.6.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.6.11.3. Product Benchmarking
      • 8.6.11.4. Strategic Initiatives
    • 8.6.12 Oxford Instruments Plc
      • 8.6.12.1. Overview
      • 8.6.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.6.12.3. Product Benchmarking
      • 8.6.12.4. Strategic Initiatives
    • 8.6.13 Zeiss International
      • 8.6.13.1. Overview
      • 8.6.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.6.13.3. Product Benchmarking
      • 8.6.13.4. Strategic Initiatives
    • 8.6.14 Shimadzu Corporation
      • 8.6.14.1. Overview
      • 8.6.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.6.14.3. Product Benchmarking
      • 8.6.14.4. Strategic Initiatives

List of Tables

  • Table 1 NIH common fund awards for biomedical research
  • Table 2 Business grants for life science and biotech in Canada
  • Table 3 PMDA-approved regenerative medicine, April, 2015-January, 2022
  • Table 4 Top biologic drugs in the U.S.
  • Table 5 Sequencing-related preparation procedures and their use
  • Table 6 Automated nucleic acid extraction systems
  • Table 7 Gene discoveries and its application in personalized treatment for neurologic diseases
  • Table 8 List of FDA approved molecular tests by key players for COVID-19 diagnosis
  • Table 9 Illumina workflows to address COVID-19
  • Table 10 Proteomics techniques: advantages and disadvantages
  • Table 11 Recent launch of automated sample preparation system by key market players
  • Table 12 Manufacturers & suppliers operational in the U.S.: laboratory glassware
  • Table 13 Key vendors and models for mass spectrometry instruments
  • Table 14 NGS instruments: comparison
  • Table 15 Cloning related service providers in the U.S.
  • Table 16 Sanger sequencing cleanup kits: types
  • Table 17 Protein lysis buffers for different protein locations
  • Table 18 Total protein extraction reagents for laboratory use
  • Table 19 Applications of proteomics in food and nutrition industry
  • Table 20 Key companies adopting expansion strategy
  • Table 21 Key companies adopting partnership strategy
  • Table 22 Key companies adopting collaboration strategy
  • Table 23 Key companies launching new products/services
  • Table 24 Key companies adopting acquisition strategy
  • Table 25 Key companies adopting other strategies
  • Table 26 List of Secondary Sources
  • Table 27 List of Abbreviations
  • Table 28 Global Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 29 Global Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 30 Global Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 31 Global Life Science Tools Market, by Region, 2018 - 2030 (USD Billion)
  • Table 32 North America Life Science Tools Market, by Country, 2018 - 2030 (USD Billion)
  • Table 33 North America Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 34 North America Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 35 North America Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 36 U.S. Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 37 U.S. Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 38 U.S. Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 39 Canada Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 40 Canada Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 41 Canada Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 42 Europe Life Science Tools Market, by Country, 2018 - 2030 (USD Billion)
  • Table 43 Europe Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 44 Europe Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 45 Europe Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 46 Germany Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 47 Germany Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 48 Germany Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 49 UK Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 50 UK Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 51 UK Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 52 France Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 53 France Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 54 France Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 55 Italy Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 56 Italy Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 57 Italy Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 58 Spain Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 59 Spain Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 60 Spain Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 61 Denmark Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 62 Denmark Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 63 Denmark Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 64 Norway Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 65 Norway Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 66 Norway Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 67 Sweden Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 68 Sweden Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 69 Sweden Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 70 Asia Pacific Life Science Tools Market, by Country, 2018 - 2030 (USD Billion)
  • Table 71 Asia Pacific Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 72 Asia Pacific Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 73 Asia Pacific Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 74 China Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 75 China Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 76 China Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 77 Japan Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 78 Japan Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 79 Japan Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 80 India Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 81 India Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 82 India Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 83 South Korea Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 84 South Korea Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 85 South Korea Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 86 Australia Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 87 Australia Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 88 Australia Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 89 Thailand Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 90 Thailand Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 91 Thailand Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 92 Latin America Life Science Tools Market, by Country, 2018 - 2030 (USD Billion)
  • Table 93 Latin America Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 94 Latin America Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 95 Latin America Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 96 Brazil Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 97 Brazil Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 98 Brazil Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 99 Mexico Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 100 Mexico Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 101 Mexico Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 102 Argentina Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 103 Argentina Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 104 Argentina Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 105 Middle East and Africa Life Science Tools Market, by Country, 2018 - 2030 (USD Billion)
  • Table 106 Middle East and Africa Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 107 Middle East and Africa Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 108 Middle East and Africa Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 109 South Africa Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 110 South Africa Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 111 South Africa Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 112 Saudi Arabia Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 113 Saudi Arabia Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 114 Saudi Arabia Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 115 UAE Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 116 UAE Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 117 UAE Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 118 Kuwait Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 119 Kuwait Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 120 Kuwait Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Executives contacted
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Analysis of individual techniques for global market modeling
  • Fig. 10 Ancillary market analysis
  • Fig. 11 Commodity flow analysis modeling for nucleic acid preparation market
  • Fig. 12 Key products
  • Fig. 13 Comparison of 3D cell culture techniques
  • Fig. 14 Technology offerings of key players in 3D cell culture market
  • Fig. 15 Next-generation sequencing market: penetration of key players
  • Fig. 16 Transfection electroporation market: penetration of key players
  • Fig. 17 QFD modeling for market share assessment of technologies
  • Fig. 18 Commodity flow analysis modeling for end users
  • Fig. 19 Penetration of key players in the academic/government end-use segment
  • Fig. 20 End-use specific revenues generated by Agilent Technologies
  • Fig. 21 Market snapshot
  • Fig. 22 Segment snapshot
  • Fig. 23 Competitive landscape snapshot
  • Fig. 24 Life science tools market segmentation
  • Fig. 25 Market driver impact
  • Fig. 26 Cell therapies under investigation, by country
  • Fig. 27 Cell therapies under investigation, by type
  • Fig. 28 Clinical trials conducted for gene therapy
  • Fig. 29 Market restraint impact
  • Fig. 30 Penetration and growth prospect mapping
  • Fig. 31 Key macroeconomic challenges associated with the pandemic
  • Fig. 32 Key elements to enhance the supply chain post COVID
  • Fig. 33 Types of COVID-19 tests
  • Fig. 34 Role of NGS to combat COVID-19 outbreak
  • Fig. 35 SWOT analysis, by factor (Political & legal, economic, and technological)
  • Fig. 36 Porter's five forces analysis
  • Fig. 37 Life science tools market: technology outlook and key takeaways
  • Fig. 38 Life science tools market: technology movement analysis
  • Fig. 39 Genomic technology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 40 Proteomics technology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 41 Cell biology technology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 42 Other analytical & sample preparation technology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 43 Lab supplies & technology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 44 Life science tools market: product outlook and key takeaways
  • Fig. 45 Life science tools market: product movement analysis
  • Fig. 46 Life science tools market for cell culture systems & 3D cell culture, 2018 - 2030 (USD Billion)
  • Fig. 47 Life science tools market estimates and forecast for cell culture systems & 3D cell culture by product, 2018 - 2030 (USD Billion)
  • Fig. 48 Life science tools market for liquid chromatography, 2018 - 2030 (USD Billion)
  • Fig. 49 Life science tools market estimates and forecast for LC, by product, 2018 - 2030 (USD Billion)
  • Fig. 50 Life science tools market for mass spectrometry, 2018 - 2030 (USD Billion)
  • Fig. 51 Life science tools market estimates and forecast for MS, by product, 2018 - 2030 (USD Billion)
  • Fig. 52 Life science tools market estimates and forecast for NGS, 2018 - 2030 (USD Billion)
  • Fig. 53 Life science tools market estimates and forecast for NGS, by product, 2018 - 2030 (USD Billion)
  • Fig. 54 Life science tools market estimates and forecast for PCR & qPCR, 2018 - 2030 (USD Billion)
  • Fig. 55 Life science tools market estimates and forecast for PCR & qPCR, by product, 2018 - 2030 (USD Billion)
  • Fig. 56 Life science tools market for flow cytometry, 2018 - 2030 (USD Billion)
  • Fig. 57 Life science tools market estimates and forecast for flow cytometry, by product, 2018 - 2030 (USD Billion)
  • Fig. 58 Life science tools market for nuclear magnetic resonance spectroscopy, 2018 - 2030 (USD Billion)
  • Fig. 59 Life science tools market estimates and forecast for NMR, by product, 2018 - 2030 (USD Billion)
  • Fig. 60 Life science tools market for microscopy & electron microscopy, 2018 - 2030 (USD Billion)
  • Fig. 61 Life science tools market estimates and forecast for microscopy & electron microscopy, by product, 2018 - 2030 (USD Billion)
  • Fig. 62 Life science tools market for nucleic acid preparation, 2018 - 2030 (USD Billion)
  • Fig. 63 Life science tools market estimates and forecast for NAP, by product, 2018 - 2030 (USD Billion)
  • Fig. 64 Life science tools market for transfection devices & gene delivery technologies, 2018 - 2030 (USD Billion)
  • Fig. 65 Life science tools market estimates and forecast for transfection devices & gene delivery technologies, by product, 2018 - 2030 (USD Billion)
  • Fig. 66 Life science tools market for cloning & genome engineering, 2018 - 2030 (USD Billion)
  • Fig. 67 Life science tools market estimates and forecast for cloning & genome engineering, by product, 2018 - 2030 (USD Billion)
  • Fig. 68 Cloning kits, reagents, and consumables offered by Merck
  • Fig. 69 Life science tools market for nucleic acid microarray, 2018 - 2030 (USD Billion)
  • Fig. 70 Life science tools market for nucleic acid microarray, by product, 2018 - 2030 (USD Billion)
  • Fig. 71 Life science tools market for sanger sequencing, 2018 - 2030 (USD Billion)
  • Fig. 72 Life science tools market for sanger sequencing, by product, 2018 - 2030 (USD Billion)
  • Fig. 73 Life science tools market for other separation technologies, 2018 - 2030 (USD Billion)
  • Fig. 74 Life science tools market for other separation technologies, by product, 2018 - 2030 (USD Billion)
  • Fig. 75 Life science tools market for other products & services, 2018 - 2030 (USD Billion)
  • Fig. 76 Life science tools market estimates and forecast for other products & services, by product, 2018 - 2030 (USD Billion)
  • Fig. 77 Life science tools market for others, 2018 - 2030 (USD Billion)
  • Fig. 78 Life science tools market for others, by product, 2018 - 2030 (USD Billion)
  • Fig. 79 Life science tools market: End-use outlook and key takeaways
  • Fig. 80 Life science tools market: end-use movement analysis
  • Fig. 81 Life science tools market for government & academic end use, 2018 - 2030 (USD Billion)
  • Fig. 82 Life science tools market for biopharmaceutical companies, 2018 - 2030 (USD Billion)
  • Fig. 83 Life science tools market for healthcare end use, 2018 - 2030 (USD Billion)
  • Fig. 84 Life science tools market for industry end use, 2018 - 2030 (USD Billion)
  • Fig. 85 Life science tools market for other end use, 2018 - 2030 (USD Billion)
  • Fig. 86 Regional marketplace: key takeaways
  • Fig. 87 North America: SWOT analysis
  • Fig. 88 North America life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 89 Key country dynamics
  • Fig. 90 U.S. life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 91 Key country dynamics
  • Fig. 92 Canada life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 93 Europe: SWOT analysis
  • Fig. 94 Europe life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 95 Key country dynamics
  • Fig. 96 Germany life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 97 Key country dynamics
  • Fig. 98 UK life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 99 Key country dynamics
  • Fig. 100 France life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 101 Key country dynamics
  • Fig. 102 Italy life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 103 Key country dynamics
  • Fig. 104 Market scenario
  • Fig. 105 Key country dynamics
  • Fig. 106 Spain life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 107 Switzerland life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 108 Key country dynamics
  • Fig. 109 Current and upcoming biotech companies investments in Eastern Denmark
  • Fig. 110 Regulatory framework
  • Fig. 111 Denmark life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 112 Key country dynamics
  • Fig. 113 Top Biotechnology Companies, Based on revenue as of 2021
  • Fig. 114 Regulatory framework
  • Fig. 115 Norway life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 116 Key country dynamics
  • Fig. 117 Top biotechnology companies, based on revenue as of 2021
  • Fig. 118 Cancer prevalence
  • Fig. 119 Regulatory framework
  • Fig. 120 Sweden life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 121 Europe: SWOT analysis
  • Fig. 122 Asia Pacific life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 123 Key country dynamics
  • Fig. 124 Japan life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 125 Key country dynamics
  • Fig. 126 Regulatory framework
  • Fig. 127 Regulatory scenario
  • Fig. 128 Reimbursement scenario
  • Fig. 129 China life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 130 Key country dynamics
  • Fig. 131 India life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 132 Key country dynamics
  • Fig. 133 Trend of public R&D projects for personalized medicine by technology clusters
  • Fig. 134 Regulatory framework
  • Fig. 135 Reimbursement Scenario
  • Fig. 136 South Korea life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 137 Key country dynamics
  • Fig. 138 Australia life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 139 Singapore life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 140 Key country dynamics
  • Fig. 141 Thailand key disease prevalence
  • Fig. 142 Regulatory framework
  • Fig. 143 Reimbursement scenario
  • Fig. 144 Thailand life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 145 Latin America: SWOT analysis
  • Fig. 146 Latin America life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 147 Key country dynamics
  • Fig. 148 Regulatory scenario
  • Fig. 149 Reimbursement scenario
  • Fig. 150 Argentina life sciences tools estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 151 Key country dynamics
  • Fig. 152 Regulatory framework
  • Fig. 153 Brazil life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 154 Key country dynamics
  • Fig. 155 Mexico life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 156 MEA: SWOT analysis
  • Fig. 157 MEA life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 158 Key country dynamics
  • Fig. 159 Reimbursement scenario
  • Fig. 160 Regulatory framework
  • Fig. 161 South Africa. life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 162 Key country dynamics
  • Fig. 163 Regulatory framework
  • Fig. 164 UAE life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 165 Key country dynamics
  • Fig. 166 Reimbursement scenario
  • Fig. 167 Saudi Arabia life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 168 Key country dynamics
  • Fig. 169 Key development in healthcare sector of Kuwait
  • Fig. 170 Regulatory framework
  • Fig. 171 Kuwait life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 172 Market participant categorization
  • Fig. 173 Life science tools market share analysis, 2022
  • Fig. 174 Strategic framework